« Previous
Next »
European Journal of Cancer
Volume 44, Issue 1
, Pages
19-24
, January 2008
Endpoints and other considerations in phase I studies of targeted anticancer therapy: Recommendations from the task force on Methodology for the Development of Innovative Cancer Therapies (MDICT)
To access this article, please choose from the options below
PII: S0959-8049(07)00589-8
doi: 10.1016/j.ejca.2007.07.034
© 2007 Elsevier Ltd. All rights reserved.
« Previous
Next »
European Journal of Cancer
Volume 44, Issue 1
, Pages
19-24
, January 2008
